Arkolith/Insider Trading/AXSM/Form 4

Mahony Susan

DirectorAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jun 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$145K
Net Open-Market Flow
-$145K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2026Sell(S)300$246.18$74K829
Jun 9, 2026Sell(S)300$237.21$71K1K
Jun 8, 2026Option exercise(M)1K——1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 8, 2026Option exercise(M)1K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-266435) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML